L2 Asset Management’s CureVac CVAC Stock Holding History

L2 Asset Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,756	Closed	-$89.3K	–	405
2025 Q4	$89.3K	Buy	19,756 +5,495	+39%	+$28.2K	0.01%	363
2025 Q3	$76.9K	Buy	14,261 +1,438	+11%	+$7.78K	0.01%	362
2025 Q2	$69.6K	Buy	+12,823	New	+$50.9K	0.01%	359

L2 Asset Management's CVAC Position: Q1 2026 in Review

L2 Asset Management sold out of CureVac (CVAC) in Q1 2026, closing a stake of 19,756 shares — an estimated $89.3K sold.

L2 Asset Management first reported a position in CVAC in Q2 2025 and held it in 3 quarters. The position peaked at $89.3K in Q4 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

L2 Asset Management reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
L2 Asset Management sold 19,756 CureVac shares in Q1 2026, an estimated $89.3K.
L2 Asset Management first reported a position in CureVac in Q2 2025 and held it in 3 quarters.
L2 Asset Management's CureVac position peaked at $89.3K in Q4 2025.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on L2 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.